Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate

Harvey S Hecht1, Leslee Shaw2, Y S Chandrashekhar3

  • 1Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Saint Luke's Medical Center, 1111 Amsterdam Ave, New York, NY, USA.

Insights

The National Institute of Health and Care Excellence now recommends coronary computed tomography angiography for stable chest pain, differing from guidelines favoring stress testing. This review debates the pros and cons of these diagnostic approaches for coronary artery disease.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Clinical Guidelines

Background:

  • The 2016 National Institute of Health and Care Excellence (NICE) guidelines shifted chest pain assessment, prioritizing coronary computed tomography angiography (CCTA).
  • Previous NICE guidelines (2012) and current guidelines from the American College of Cardiology Foundation/American Heart Association and European Society of Cardiology emphasize stress testing for stable chest pain.
  • This divergence creates a debate on the optimal diagnostic pathway for patients with stable chest pain and no confirmed coronary artery disease.

Purpose of the Study:

  • To present a debate on the advantages and disadvantages of differing clinical recommendations for stable chest pain diagnosis.
  • To critically review the literature supporting CCTA versus stress testing as the primary diagnostic modality.
  • To project future research needs and guide readers in drawing their own conclusions on the best diagnostic approach.

Main Methods:

  • Literature review of studies comparing CCTA and stress testing for stable chest pain.
  • Analysis of current clinical guidelines from major cardiology organizations (NICE, ACCF/AHA, ESC).
  • Debate format presenting pros and cons of each diagnostic strategy.

Main Results:

  • NICE guidelines now advocate CCTA as a first-line investigation for stable chest pain, moving away from pre-test probability calculations.
  • Major US and European cardiology guidelines continue to recommend functional stress testing as the preferred initial diagnostic modality.
  • The review highlights a significant shift in diagnostic strategy by NICE, contrasting with established international recommendations.

Conclusions:

  • The optimal diagnostic strategy for stable chest pain remains a subject of debate, with differing recommendations from key guideline bodies.
  • Further research is needed to fully elucidate the long-term implications and comparative effectiveness of CCTA versus stress testing.
  • Readers are encouraged to weigh the evidence presented to determine the most appropriate diagnostic pathway for their clinical practice.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.5K